MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. is a publicly traded company headquartered in New York City [1]. The company is listed on the Nasdaq exchange under the ticker symbol INKT [2]. According to Securities and Exchange Commission filings, MiNK Therapeutics operates in the biological products industry, excluding diagnostic substances [3]. The company was previously registered with the SEC under the name AgenTus Therapeutics, Inc. [4]. As of its most recent annual report, MiNK Therapeutics reported total assets of $14.2 million [5].
NYC headquarters
- SEC filings list the business address of MiNK Therapeutics, Inc. as 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010.[1]
Something wrong or missing? Send a correction. Fixed within 24 hours.